Overview

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Gaboxadol
Criteria
Inclusion Criteria:

- patients with a diagnosis of primary insomnia